Mark Wilterding
Chief Financial Officer · 2 filings · Latest: Feb 28, 2026
RxSight, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXST | Mark Wilterding | Chief Financial Officer | Feb 28, 2026 | Option Exercise | — | 20,441 | — | 20,441 |